POLK and lymphoma: In conclusion, the genetic knockout of Polk in a p53-KO murine lymphoma strongly enhanced the cytotoxicity of cisplatin, resulting in marked increased in the overall survival time of Polk-KO tumor bearing mice that were treated with cisplatin.